about
KSHV-Mediated Angiogenesis in Tumor ProgressionTargeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and FutureKaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinaseRegulation of PI3K/Akt dependent apoptotic markers during b virus infection of human and macaque fibroblasts.Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphomaAltering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.Molecular biology of KSHV lytic reactivation.Novel functions of viral anti-apoptotic factors.The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedsideRestricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic ReplicationA KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT SignalingA KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.The Akt signaling pathway is required for tissue maintenance and regeneration in planariansMiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signalingAge-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus.Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line.Postpartal subclinical endometritis alters transcriptome profiles in liver and adipose tissue of dairy cows.Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice.Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Augments Viral Lytic Replication.Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.The role of the microbiome in cancer development and therapy.Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes.Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.PI3K Signaling in B Cell and T Cell Biology.Fortunellin-Induced Modulation of Phosphatase and Tensin Homolog by MicroRNA-374a Decreases Inflammation and Maintains Intestinal Barrier Function in Colitis.Marek's Disease Virus Activates the PI3K/Akt Pathway Through Interaction of Its Protein Meq With the P85 Subunit of PI3K to Promote Viral Replication
P2860
Q26742030-66D35AD4-3249-4B45-BB3C-60377A0F5C22Q28081199-918BA0D6-F125-42EA-A339-B48B3450D8D5Q28388436-5566653F-2796-43A3-A051-BCF59E397FF5Q28538376-9EFDB543-B15E-4060-9449-62034F7560ADQ30100963-301DA2F5-4ECF-417A-B8D0-0A30D701D0EDQ30409463-032FA025-84A8-4BC3-BA6E-97594D231A39Q34541350-553624EE-D5DB-4E26-AB8A-18677AD058A3Q35014918-402D9D72-7958-4800-BDF0-48435E3C15C3Q35571982-E62D95FC-5D32-4F6C-B053-887D0EBDAAF5Q35582498-EB6167B1-8B9E-4261-902B-A9888D88612FQ35640940-1AB2481C-A2A4-4464-9329-A26C81F7A4DBQ35680401-54542396-CDC0-42BB-9920-2C0057622053Q35786739-7C068495-30F8-48FC-AF5A-754B6D1AD29CQ35983671-A1BD3EFF-4362-4E30-8BD2-0E756DD66EC0Q35986496-C3EB03F0-E728-4F61-A980-FC02E29E02E8Q36228081-B5748BAF-35D4-4D80-B317-DE907DE48BFCQ36460797-70F6B152-C365-49C1-8319-85BEEF2E8AC6Q37418380-B640181B-90AC-4D36-9811-FE01EE9E3696Q37603310-5C511959-9CFA-44B8-BFA7-E39374E677F6Q37676300-296ABE33-0BE6-4713-95D2-2A08DF7427EEQ38114627-809A6B93-740E-4BE6-ADD8-E95C91C58D13Q38550685-81B2FA64-BA9E-4F9D-99A1-FA13973E1AADQ38764215-1804D47B-155F-4C02-8513-5AFE9EBF8C9DQ39103566-AC42D6FA-3B80-44B7-BDA0-C5EC8B76D332Q39173806-98B9ACDA-30B9-4F40-8500-5D3788A843E5Q39284842-A984BC99-B7D9-4425-B012-1E199B38EAEBQ39290620-A1A7CA1D-967B-44ED-BB8E-854081B2E8EDQ39792977-DD721417-323D-43D2-94B3-588BB60369BEQ40144368-C7FC3E7A-7E2C-4C07-9B7B-3841128958CDQ42026999-21CC91BF-A1F3-4B27-9F03-2FA8BBEC09ADQ42366342-B6BE92C5-ABEE-4D9C-BE39-AD2914DBEBA5Q42972198-95230926-E820-4C67-BEFE-37A9280558C8Q50284482-747250B5-80E3-4254-A4E0-5C90C77EE621Q58572756-4389CDF5-8B9F-43F0-9E7A-E7E5AF79AA3E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.
@en
type
label
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.
@en
prefLabel
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.
@en
P2860
P356
P1476
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.
@en
P2093
Aadra P Bhatt
P2860
P356
10.3389/FIMMU.2012.00401
P577
2012-01-01T00:00:00Z